Loading provider…
Loading provider…
Neurology Physician in Bakersfield, CA
NPI: 1285825455Primary Practice Location
Jeri Yvonne Movement Disorders Neurology Inc.
8327 Brimhall Rd, Bakersfield, CA
Primary Employer
Jeri Yvonne Movement Disorders Neurology Inc.
drjeriyvonneneurology.com
HQ Phone
Get M.D. Jeri's Phone Numberphone_androidMobile
Get M.D. Jeri's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
MT State Medical License
2025 - 2027
CA State Medical License
2012 - 2026
OR State Medical License
2025 - 2025
AL State Medical License
2011 - 2013

American Board of Psychiatry and Neurology
Neurology
University of Alabama Medical Center
Fellowship • Neuromuscular Medicine (Neurology)
2011 - 2013
Rutgers Health/Robert Wood Johnson Medical School
Residency • Neurology
2008 - 2011
Center for Family Medicine
Internship • Transitional Year
2007 - 2008
American University of the Caribbean School of Medicine
Medical School
Until 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 259 | 441 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 112 | 172 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 56 | 56 |
| 4 | 99203New patient outpatient visit, total time 30-44 minutes | 21 | 21 |
Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease
Authors: Neil A. Kelly, Matthew P. Ford, David G. Standaert, Ray L. Watts, C. Scott Bickel
External quality assurance of tricyclic antidepressant measurements in serum: eight years of progress?
Authors: Wilson JF, Tsanaclis LM, Williams J, Tedstone JE, Richens A
Publication Date: 1989-01
Lead Sponsor: ACADIA Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Pimavanserin 20 mg, DRUG: Pimavanserin 34 mg